?
?
聯科生物固定破膜劑(Fix&Perm)質量優秀,操作簡單,深受廣大科研人員好評與喜愛,具有以下三大優點:
?
1、破膜后細胞分群保持完好
?
2、溶血、破膜、染色一步完成,節約成本,操作簡便
?
3、保持抗體的特異性、靈敏度以及可重復性
?



?
聯科生物固定破膜劑產品列表:
?
|
廠商 |
目錄號 |
產品名稱 |
規格 |
目錄價 |
|
MultiSciences |
50T |
560 |
||
|
MultiSciences |
100T |
1060 |
||
|
MultiSciences |
200T |
1960 |
||
|
MultiSciences |
1000T |
8760 |
||
|
MultiSciences |
50T |
360 |
?
?
引用聯科固定破膜劑部分參考文獻:
[1]?Yin Q, Shen J, Chen L, et al. Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly (β-amino esters)[J]. Biomaterials, 2012, 33(27): 6495-6506..?(IF: 8.55)
[2]?Yin Q, Zhang Z, et al. Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance[J]. Biomacromolecules, 2013, 14(7): 2242-2252.(IF:5.75)
[3]?Yang Y, Gao Y, Chen L, et al. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles[J]. International journal of pharmaceutics, 2011, 405(1): 188-195.?(IF:3.65)
[4]?Yuan C, Zhang H, Wang W, et al. Transmembrane protein 63A is a partner protein of Haemonchus contortus galectin in the regulation of goat peripheral blood mononuclear cells[J]. Parasites & vectors, 2015, 8(1): 211.?(IF:3.43)
[5]?Yan L, Xie K M, Yang G Q, et al. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.[J]. Cancer Chemotherapy & Pharmacology, 2009, 66(3):433-439.(IF: 2.76)
[6]?Zhang H X, Zhu B, Fu X X, et al. BTLA associates with increased Foxp3 expression in CD4+ T cells in dextran sulfate sodium-induced colitis[J]. International journal of clinical and experimental pathology, 2015, 8(2): 1259.?(IF: 1.89)
[7]?Zhang Q, Deng C, Rao F, et al. Silencing of desmoplakin decreases connexin43/Nav1. 5 expression and sodium current in HL 1 cardiomyocytes[J]. Molecular medicine reports, 2013, 8(3): 780-786.?(IF: 1.55)
[8]?Li X, Wang Y, Han C, et al. Colorectal cancer progression is associated with accumulation of Th17 lymphocytes in tumor tissues and increased serum levels of interleukin-6[J]. The Tohoku journal of experimental medicine, 2014, 233(3): 175-182.?(IF: 1.35)
?
